This Medudy course is a video tutorial for physicians on the topic of "Tapinarof cream for atopic dermatitis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
"Tapinarof Cream 1% once daily" is a topical aryl hydrocarbon receptor agonist. It downregulates pro-inflammatory Th2 cytokines, upregulates skin barrier components and reduces oxidative stress. Today's study was designed to evaluate the efficacy and safety of tapinarof in adults and children up to 2 years of age with atopic dermatitis.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this training, you will know:
- the clinical background and relevance of the research question investigated
- the study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
